EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension

Jitesh Singh Rathee, Dhanya R Iyer, Malapaka Kiranmayi, Samarasimha Reddy, V V Sureshbabu, Nitish R Mahapatra iD

Bioscience Reports · 2024

DOI: 10.1042/bsr20241433 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience Reports, 2024. Verfasst von Jitesh Singh Rathee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai 400085, India. Hauptthemen laut MEDLINE: Hypertension, Chromogranin A, Peptide Fragments, Blood Pressure. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Atomic Energy, Government of India (DAE), Department of Biotechnology, Ministry of Science and Technology, India (DBT).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Catestatin (CST), a 21-amino acids physiological peptide, has emerged as a key modulator of cardiovascular functions due to its anti-hypertensive and cardioprotective properties. However, the ramifications of the most common human variant of CST (viz., Gly364Ser) on cardiovascular pathophysiology remain partially understood. In this study, hypertension was induced in uninephrectomized rats by treatment with deoxycorticosterone-acetate and sodium chloride (DOCA-salt). The DOCA-salt-induced hypertensive (DSHR) animals were then intraperitoneally administered with either CST wild-type (CST-WT) or 364Ser variant (CST-Ser) peptide. CST-Ser was profoundly less effective than CST-WT in rescuing the elevated systolic blood pressure [from ∼211 mmHg to ∼176 mmHg, p < 0.0001 (CST-Ser) versus ∼116 mmHg, p < 0.0001 (CST-WT)] and heart rate [from ∼356 bpm to ∼314 bpm, p = 0.66 (CST-Ser) versus ∼276 bpm, p = 0.02 (CST-WT)]. CST-Ser also showed diminished effects in lowering diastolic blood pressure and mean arterial pressure in the DSHR animals. Furthermore, CST-Ser was inefficient/markedly less potent in rescuing the impaired contractile and diastolic function in DSHR animals [improvements in the contractility index by ∼22 s–1 (CST-Ser), p = 0.15 versus by ∼84 s–1 (CST-WT), p < 0.0001 and decrease in end-diastolic pressure by ∼4 mmHg (CST-Ser), p = 0.015 versus by ∼14 mmHg (CST-WT), p < 0.0001]. Moreover, CST-Ser exerted less potent anti-inflammatory effects on the DSHR hearts than CST-WT. These findings are in concordance with the elevated systolic/diastolic blood pressure observed in Ser variant carriers from various human populations. This study provides compelling evidence for the diminished anti-hypertensive and cardioprotective effects of the CST-Gly364Ser variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionChromogranin APeptide FragmentsBlood PressureAntihypertensive AgentsHeart RateDisease Models, AnimalAnimalsRatsMaleHumansDesoxycorticosterone AcetateRats, Sprague-Dawley

Stichwörter der Autor:innen

blood pressurecardioprotectioncatestatinhuman genetic variantinflammation

Substanzen

chromogranin A (344-364)Chromogranin APeptide FragmentsAntihypertensive AgentsDesoxycorticosterone Acetate

Autor:innen und Institutionen

  • Bio-Organic Division, Bhabha Atomic Research Centre, Mumbai 400085, India.
  • Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai 600036, India.
  • Department of Studies in Chemistry, Central College Campus, Bangalore University, Dr. B. R. Ambedkar Veedhi, Bangalore 560001, India.

ORCID-Profile: Nitish R Mahapatra

Förderung

  • Department of Atomic Energy, Government of India (DAE)
  • Department of Biotechnology, Ministry of Science and Technology, India (DBT)

Zitieren

APA

Rathee, J. S., Iyer, D. R., Kiranmayi, M., Reddy, S., Sureshbabu, V. V., & Mahapatra, N. R. (2024). The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension. Bioscience Reports. https://doi.org/10.1042/bsr20241433

Vancouver

Rathee JS, Iyer DR, Kiranmayi M, Reddy S, Sureshbabu VV, Mahapatra NR. The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension. Bioscience Reports. 2024. doi:10.1042/bsr20241433

BibTeX
@article{Rathee2024,
  author = {Rathee, Jitesh Singh and Iyer, Dhanya R and Kiranmayi, Malapaka and Reddy, Samarasimha and Sureshbabu, V V and Mahapatra, Nitish R},
  title = {The physiological anti-hypertensive peptide catestatin and its common human variant Gly364Ser: differential cardiovascular effects in a rat model of hypertension},
  journal = {Bioscience Reports},
  year = {2024},
  doi = {10.1042/bsr20241433}
}
Kostenlos starten →